Equibles does not estimate personal net worth.
Get an email with a short summary when BioStem Technologies, Inc. publishes a filing, an earnings call transcript or a press release.
Get BSEM alertsBrandon Poe is recorded as CFO at BioStem Technologies, Inc. (BSEM). Brandon Poe has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for BioStem Technologies, Inc. on August 12, 2026. BioStem Technologies, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“In the second quarter, revenue was $7.9 million compared with $6.1 million in the first quarter of 2026. The sequential increase reflects continued execution against our hospital-focused strategy, including the ramp-up of the expanded sales organization and increased utilization across our GPO contract base.”
“To start, I want to give some context around the seasonality we expect in our quarterly revenues now that the vast majority of our sales will be generated in the hospital business.”
“Yeah, I mean, I think it's going to take, to get back to profitability of that question, it's going to take a little more revenue growth there. As you said, I mean, the majority of the revenue is going to be in the hospital space.”
“Turning to our fourth quarter results, our revenue totaled $10.1 million compared to $10.5 million in the prior period and $22.7 million in the fourth quarter of 2024.”
Biotechnology · Healthcare
CFO
